As of 2025-05-05, the Relative Valuation of Translate Bio Inc (TBIO) is (5,741.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.23 USD, the upside of Translate Bio Inc based on Relative Valuation is -177857.1%.
The range of the Relative Valuation is (4,755.60) - (7,765.90) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.1x - 45.9x | 37.0x |
| Forward P/E multiples | 24.1x - 46.7x | 30.9x |
| Fair Price | (4,755.60) - (7,765.90) | (5,741.55) |
| Upside | -147332.1% - -240530.2% | -177857.1% |
| Date | P/E |
| 2025-04-25 | -0.01 |
| 2025-04-24 | -0.01 |
| 2025-04-23 | -0.01 |
| 2025-04-22 | -0.00 |
| 2025-04-21 | -0.01 |
| 2025-04-17 | -0.01 |
| 2025-04-16 | -0.01 |
| 2025-04-15 | -0.00 |
| 2025-04-14 | -0.00 |
| 2025-04-11 | -0.01 |
| 2025-04-10 | -0.01 |
| 2025-04-09 | -0.00 |
| 2025-04-08 | -0.00 |
| 2025-04-07 | -0.00 |
| 2025-04-04 | -0.00 |
| 2025-04-03 | -0.00 |
| 2025-04-02 | -0.00 |
| 2025-03-31 | -0.00 |
| 2025-03-28 | -0.00 |
| 2025-03-27 | -0.00 |
| 2025-03-26 | -0.00 |
| 2025-03-25 | -0.00 |
| 2025-03-24 | -0.00 |
| 2025-03-20 | -0.00 |
| 2025-03-19 | -0.00 |
| 2025-03-18 | -0.00 |
| 2025-03-17 | -0.00 |
| 2025-03-14 | -0.00 |
| 2025-03-13 | -0.00 |
| 2025-03-12 | -0.00 |
| 2025-03-11 | -0.00 |
| 2025-03-10 | -0.00 |
| 2025-03-07 | -0.00 |
| 2025-03-06 | -0.00 |
| 2025-03-05 | -0.00 |
| 2025-03-04 | -0.00 |
| 2025-03-03 | -0.00 |
| 2025-02-28 | -0.00 |
| 2025-02-27 | -0.00 |
| 2025-02-26 | -0.00 |
| 2025-02-25 | -0.00 |
| 2025-02-24 | -0.00 |
| 2025-02-21 | -0.00 |
| 2025-02-20 | -0.00 |
| 2025-02-19 | -0.00 |
| 2025-02-18 | -0.00 |
| 2025-02-14 | -0.00 |
| 2025-02-13 | -0.00 |
| 2025-02-12 | -0.00 |
| 2025-02-11 | -0.00 |